Pharmaniaga Berhad (KLSE:PHARMA)
Malaysia
· Delayed Price · Currency is MYR 0.240
-0.020 (-7.69%)
At close: Mar 9, 2026
Pharmaniaga Berhad Revenue
In the year 2025, Pharmaniaga Berhad had annual revenue of 3.93B MYR with 4.48% growth. Pharmaniaga Berhad had revenue of 938.28M in the quarter ending December 31, 2025, with 1.28% growth.
Revenue
3.93B
Revenue Growth
+4.48%
P/S Ratio
0.40
Revenue / Employee
1.12M
Employees
3,502
Market Cap
1.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.93B | 168.27M | 4.48% |
| Dec 31, 2024 | 3.76B | 355.00M | 10.43% |
| Dec 31, 2023 | 3.40B | -76.45M | -2.20% |
| Dec 31, 2022 | 3.48B | -1.33B | -27.71% |
| Dec 31, 2021 | 4.82B | 2.09B | 76.69% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CTOS Digital Berhad | 326.06M |
| Hap Seng Plantations Holdings Berhad | 702.40M |
| RCE Capital Berhad | 236.69M |
| Spritzer Bhd | 656.85M |
| Eastern & Oriental Berhad | 868.45M |
| Radium Development Berhad | 199.22M |
| Sports Toto Berhad | 6.53B |
| Ideal Capital Berhad | 1.24B |